Madam Speaker, I thank the member for Vancouver Kingsway for his comments. There is a lot of history there and knowledge as well.
I would like to the ask the member, as the health critic, what some of the concerns are that he may have with respect to the TPP on health implications, particularly with respect to pharmacare.